NEW YORK (GenomeWeb News) — Illumina has sold 1,000 of its HumanHap550 BeadChips to GlaxoSmithKline, Illumina said today.
 
Under the agreement, GSK will use Illumina’s services and hardware at a “third party facility” in what Illumina said is a continuation and expansion of an existing genotyping arrangements between the two companies.
 
The firms have had running genotyping agreements for more than five years.
 
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.